Lineage Cell Therapeutics
LCTX
#8903
Rank
S$0.13 B
Marketcap
$0.60
Share price
-6.12%
Change (1 day)
-60.54%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -S$28.81 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are S$9.49 Million. , an increase over its 2023 earnings that were of -S$32.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 -S$28.1 Million-13.16%
2023 -S$32.36 Million9.83%
2022 -S$29.46 Million-54.24%
2021 -S$64.38 Million86.07%
2020 -S$34.6 Million-31.97%
2019 -S$50.86 Million-5.42%
2018 -S$53.77 Million1.1%
2017 -S$53.19 Million-31.06%
2016 -S$77.14 Million-10.38%
2015 -S$86.08 Million29.69%
2014 -S$66.38 Million31.68%
2013 -S$50.41 Million
2011 -S$24.47 Million89.78%
2010 -S$12.89 Million206.06%
2009 -S$4.22 Million-0.58%
2008 -S$4.24 Million164.89%
2007 -S$1.6 Million-30.22%
2006 -S$2.3 Million
2002 -S$2.67 Million-41.04%
2001 -S$4.52 Million-32.04%
2000 -S$6.65 Million-11.85%
1999 -S$7.54 Million
1997 -S$4.85 Million12.12%
1996 -S$4.32 Million106.25%
1995 -S$2.1 Million-11.11%
1994 -S$2.36 Million50%
1993 -S$1.57 Million20%
1992 -S$1.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.19 Billion 565.31%๐Ÿ‡บ๐Ÿ‡ธ USA